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Abstract (word count: 221) 
Objective(s): Despite the widespread use of carbon dioxide insufflation (CDI) in cardiac 
surgery, there is still paucity of evidence to prove its benefit in terms of neurological protection. 
Therefore, we conducted a meta-analysis of available randomized controlled trials (RCT) 
comparing CDI versus standard de-airing manoeuvres.   
Methods: Electronic searches were performed to identify relevant RCTs. Primary outcomes 
investigated were postoperative stroke, neurocognitive deterioration (NCD), and in-hospital 
mortality. Risk difference (RD) was used as summary statistic. Pooled estimates were obtained 
by means of random-effects model to account the possible clinical diversity and methodologic 
variation between studies. 
Results: A total of 8 studies were identified with 668 patients randomized to CDI (n=332) 
versus standard de-airing manoeuvres (n=336). In hospital mortality was 2.1% versus 3.0% in 
the CDI and control group respectively (RD 0%; 95%CI -2% to 2%; P=0.87; I2=0%).  Incidence 
of stroke was similar between the two groups (1.0% versus 1.2% in the CDI and control group 
respectively (RD 0%; 95%CI -1% to 2%; P=0.62; I2=0%). NCD rate was 12% versus 21% in 
the CDI and control group respectively but this difference was not statistically significant (RD: 
-7%; 95%CI -022% to 8%; P=0.35; I2=0%).     
Conclusions: The present meta-analysis did not find any significant protective effect from the 
use CDI when compared with manual de-airing manoeuvres in terms of clinical outcomes 
including postoperative neurocognitive decline.  
Keywords: Carbon dioxide insufflation; cardiac surgery; meta-analysis   
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Central message: The present systematic review and meta-analysis showed that despite its 
widespread use, to date there is little evidence on any protective effect of carbon dioxide 
insufflation in open heart surgery.  
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Perspective Statement: Despite its widespread use, to date there is little evidence on any 
protective effect of carbon dioxide insufflation in open heart surgery. In view of the increased 
costs and increased risk of systemic hypercapnic acidosis, it seems there is an urgent need for 
further evidence to conclusively justify the routine its use during cardiac surgery.  
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Neurological impairment following cardiac surgery may take the form of stroke or 
postoperative neurocognitive deterioration (NCD). The former is devastating but fortunately 
rare. However, a decline in attention, memory, or fine motor skills can be documented in up to 
30% of patients postoperatively [1]. Neurocognitive decline particularly affects elderly patients 
and those with other comorbidities. The scale of the problem has increased in the last two 
decades due to the increasing number of older and sicker patients referred for surgery. Several 
mechanisms are implicated in cerebral injury after cardiac surgery including air 
microembolism [2]; a recent study reporting that their number correlates with the degree of 
postoperative neuropsychological disorder [3]. Various de-airing techniques have been 
proposed to minimised air microembolisation during open heart surgery [4-5].  Classical 
manual de-airing techniques have proved unsatisfactory and even when meticulously adhered 
to, large numbers of microemboli still occur [4-5]. Carbon dioxide insufflation (CDI) into the 
pericardial cavity first proposed in 1958 [6], has become widespread (video 1), the rationale 
been its increased density and solubility relative to air, potentially leading to fewer gaseous 
microemboli entering the bloodstream [7,8]. However, there is still a paucity of conclusive 
evidence to justify its routine use [9-11]. We sought to get insights into the role of CDI in open 
heart surgery by conducting a meta-analysis of available randomized controlled trials (RCT).   
Methods 
Literature Search Strategy 
This work was designed as a systematic review and network meta-analysis, with reporting 
following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis statement 
[12].  
Data sources and searches 
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Two investigators (U.B, M.C.), independently searched relevant studies on PubMed, Embase, 
BioMed Central, and the Cochrane Central register. Our aim was to find all RCTs comparing 
CDI versus de-airing manoeuvres alone in cardiac surgery. Only RCTs were included in the 
present meta-analysis. To achieve the maximum sensitivity of the search strategy and identify 
all studies, we combined the terms ‘‘carbon dioxide’’ with ‘‘randomized controlled trial’’ as 
both keywords and MeSH headings. The reference lists of all retrieved articles were reviewed 
for further identification of potentially relevant studies. All relevant articles identified were 
assessed with application of the inclusion and exclusion criteria. 
Selection Criteria 
Eligible studies for the present meta-analysis included those which met the following criteria: 
1) the studies had to include patients undergoing cardiac surgery including valve surgery+/- 
coronary artery bypass grafting (CABG), aortic vascular surgery or their combinations; 2) 
studies had to be RCTs, and to assign patients into CDI group or control group randomly. When 
centres have published duplicate trials with accumulating numbers of patients or increased 
lengths of follow-up, only the most updated reports were included for qualitative appraisal at 
each time interval. All publications were limited to human subjects. Non-English articles were 
not excluded. Abstracts, case reports, conference presentations, editorials, and expert opinions 
were excluded.  
Study end-points  
Primary outcomes of interest were: NCD, postoperative stroke, and in-hospital mortality. 
Individual study definition was adopted for NCD. Secondary outcome was the quantity of 
gaseous microemboli in heart chambers at the end of the procedure (aortic cross clamp 
removal) detected by transoesophageal echocardiogram. We also investigated creatinine 
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kinase, MB isoenzyme (CK-MB) release at 24 hours as a marker of myocardial injury 
potentially related to coronary air microembolization and hospital stay length.  
Data extraction and quality assessment 
Baseline, procedural, outcome, and follow-up data were independently abstracted by 2 
investigators. Data were analysed according to the intention-to-treat principle whenever 
possible. The internal validity and risk of bias of included trials were appraised by 2 
independent investigators (U.B., G.G.) according to the “risk of bias assessment tool” 
developed by the Cochrane collaboration [12]. Briefly, for each trial, 7 domains were assessed: 
random sequence generation, allocation concealment, blinding of participants and personnel, 
blinding of outcome assessors, incomplete outcome data reporting, selective reporting, and 
presence of other bias. Presence of possible source of bias in each domain was assessed, and a 
final judgment of low, moderate, or high risk of bias was assigned. 
Statistical Analysis 
Standard meta-analysis using Mantel-Haenszel method originally derived for odds-ratio 
estimates, does not use the information from double-zero studies. As double-zero studies point 
to no differences in treatment effects, at least in balanced trials, deleting them might bias the 
treatment effect away from the null. To account for double-zero studies in the present meta-
analysis, we used a method proposed by Greenland and Robins based on the analysis of risk 
differences (RD) for primary outcomes. For the secondary outcomes, we used standardized 
mean difference (SMD) to account for variation in outcome measurement methods used in 
individual trials. Tests were used to study heterogeneity between trials. I2 statistic was used to 
estimate the percentage of total variation across studies, owing to heterogeneity rather than 
chance. An I2 value of greater than 50% was considered substantial heterogeneity. In the 
present meta-analysis the results using the random-effects model were presented to take into 
account the possible clinical diversity and methodologic variation between studies. All P values 
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were 2-sided. Post-hoc analysis power calculation was obtained for all outcomes investigated. 
All statistical analysis was conducted with Review Manager Version 5.1.2 (Cochrane 
Collaboration, Software Update, Oxford, United Kingdom) and G*Power Version 3.1.9.2 
(Franz Faul, Germany). 
Results 
Quantity and Quality of Trials 
A total of 290 references were identified through the 5 electronic database searches. After 
exclusion of duplicate or irrelevant references, 19 potentially relevant articles were retrieved. 
After detailed evaluation of these articles, 12 studies remained for assessment. After applying 
the selection criteria, 8 RCTs [14-21] were selected for analysis (Figure 1). The study 
characteristics of these trials are summarized in Table 1,2 and 3. In these 8 studies, 668 patients 
were randomized to CDI (n=332) versus standard de-airing manoeuvres (n=336). Sample size 
determination was reported only in two out of 8 studies. Tests and timing used for 
neurocognitive assessment varied among studies. Different methods were used for carbon 
dioxide delivery. The 8 RCTs were assessed qualitatively using tools designed to measure the 
risk of bias, as recommended by the Cochrane collaboration. A summary of selection bias, 
performance bias, detection bias, attrition bias, reporting bias, and other bias identified in each 
individual RCT is presented in Figures 2. 
Meta-analysis  
Data regarding in-hospital mortality and stroke was available for all studies included (for two 
studies, authors provided data when contacted by email). A total of four RCTs (n=567) reported 
on the incidence of postoperative neurocognitive dysfunction. Five studies (n=226) reported 
on the quantity of gaseous microemboli in heart chambers at aortic cross clamp removal 
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detected by transoesophageal echocardiogram. CK-MB levels and length of stay were reported 
by 3 RCTs including 162 and 143 patients respectively.  
Meta-analytic estimates for primary and secondary outcomes are summarized in Figure 3 and 
4 respectively. In hospital mortality was 2.1% versus 3.0% in the CDI and control group 
respectively (RD 0%; 95%CI -2% to 2%; P=0.87; I2=0%).  Incidence of stroke was similar 
between the two groups (1.0% versus 1.2% in the CDI and control group respectively (RD 0%; 
95%CI -1% to 2%; P=0.62; I2=0%). Neurocognitive decline rate postoperatively was 12% 
versus 21% in the CDI and control group respectively but this difference was not statistically 
significant (RD: -7%; 95%CI -022% to 8%; P=0.35; I2=0%).  Post-hoc power calculation was 
8% for hospital mortality, 2.5% for stroke, 80% for NCD.  
The amount of gaseous microemboli detected by transoesophageal echocardiogram was 
significantly lower in the CDI group versus the control group (RD -0.94; 95%CI -1.63 to -0.25; 
P=0.008; I2=77%). Finally, CK-MB levels (SMD 0.16; 95%CI -0.41 to 0.73; P=0.58; I2=66%) 
and length of hospital stay were not different between the two groups (SMD 0.08; 95%-0.25, 
0.41; P=0.62; I2=0%).  Post-hoc power calculation was 100% for quantity of gaseous 
microemboli, 13% for CK-MB levels and 24% for hospital stay length.  
Discussion 
By pooling data from 8 RCTs including 668 patients, we found that CDI was associated with 
a smaller quantity of of gaseous microemboli in the heart chambers after cross clamp removal 
but it did not significantly influence the incidence of postoperative neurocognitive decline 
when compared to standard de-airing manoeuvres.   
The aetiology of neurological impairment following cardiac surgery is multifactorial and 
includes systemic inflammation, hypotension and microembolization during cardiopulmonary 
bypass [22]. Microemboli include atherosclerotic emboli that are often released during aortic 
 11 
 
manipulation and gaseous microemboli that occur particularly during open chamber surgery 
[23]. Although most research on cerebral embolization has focused on the issue of 
atherosclerotic microemboli, a recent study demonstrated that most emboli (~80%) are gaseous 
[23]. Gaseous microemboli are theorized to lead to cerebral injury by occluding small vessels. 
Manual de-airing techniques are commonly used but unfortunately they are unable to fully 
eliminate microemboli. Carbon dioxide insufflation into the pericardial cavity has been 
proposed to improve de-airing [5,6]. However, there is little good quality evidence to support 
its efficacy in preventing neurocognitive decline. By pooling data from available RCTs we did 
not find any significant protective effect from CO2 in terms of clinical outcomes including 
postoperative neurocognitive decline. Although the present analysis was sufficiently powered 
(80%) to detect a difference between the two groups in terms of neurocognitive decline, it was 
largely underpowered to detect difference in terms of mortality and stroke. For secondary 
outcomes such as CK-MB levels, some trials have reported results with means from very highly 
skewed distributions which increase the uncertainty of calculated estimates.   
A variety of CO2 delivery devices were used in the available trials investigating the efficacy of 
CDI. It has been shown that tubes with open end or multiperforated catheter blowing carbon 
dioxide have undesirable result of air turbulence and do not provide a satisfied de-airing 
procedure (19.5%-51.7% remaining air) [24]. The most efficient de-airing (≤1% remaining air) 
in a cardiothoracic wound model was provided by a gas diffuser at a carbon dioxide flow of 10 
L/min. In the present meta-analysis, five of the 8 studies did not use gas diffuser. Therefore, 
de-airing by CDI was likely to be ineffective in these trials and this might translate into an 
underestimation of carbon dioxide protective effect. Moreover, different battery of 
psychometric tests were used and performed at different time to assess neurological 
dysfunction. It is well known that psychometric tests are affected by anaesthesia and analgesia 
drugs, hence they may fail to distinguish the impairment that stemmed from embolism [25,26]. 
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Selnes et al. [27] reported that psychometric tests should not be performed earlier than 3 months 
postoperatively to avoid the influence of anaesthesia and analgesia. In the present meta-
analyisis, three out of 4 studies reporting on neurocognitive decline performed psychometric 
tests during the first week after surgery. They found CDI protective in terms of neurocognitive 
decline. Only Chaudhuri et al. [15] performed psychometric tests at 6 weeks postoperatively 
and concluded that CDI was not protective. Although in these trials neurocognitive decline has 
been used as a surrogate outcome for cerebral air microembolization, they cannot exclude the 
solid material embolization known to take place during open heart surgery (i.e. calcium 
fragments, platelets aggregate). Al-Rashidi et al. [14] investigated the effect of CDI on cerebral 
microembolization by means of transcranial Doppler, but they were unable to discriminate 
between gas and solid emboli. Several RCTs investigating CDI used quantity of gaseous 
microemboli in heart chambers at cross clamp time removal as primary outcome and CDI has 
been consistently associated with smaller amount of air bubbles. However, this does not 
necessarily translate into reduced cerebral gas microembolization as in principle prolonged 
standard de-airing manoeuvres can minimize this risk.  Of note, in the present meta-analysis 
blinding of operators to treatment allocation was present only in two out of 8 trials and this 
might have led surgeons to prolong standard venting manoeuvres in the control group thus 
neutralizing the effect of CDI.  
The importance placed on surrogate markers of air microembolism has resulted in different 
conclusions. Despite its widespread use, to date there is little evidence on protective effect of 
CDI in open heart surgery. In addition to the increased costs (~30$ total cost each case 
including 5$ for CO2 cylinder and 25$ for gas diffusers available on the market), CDI induces 
significant systemic hypercapnic acidosis also when standardized protocol are employed for 
continuous delivery [11].  Insufflation of CO2 into the cardiothoracic wound cavity during left-
sided cardiac surgery can induce hypercapnic acidosis and increased cerebral blood flow. The 
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finding of altered cerebral hemodynamics with CO2 insufflation raises the concern that the 
protective effects of CO2 insufflation potentially could be counterbalanced, because a higher 
number of cerebral emboli, solid or gaseous, could access the cerebral circulation on account 
of cerebral vasodilatation. The observation that hypocapnia reduced the risk of cerebral 
embolization during CPB in animal models [29] could support this theory. These systemic 
effects should be monitored by in-line capnography and acid–base measurements for early and 
effective correction by increase in gas flows to the oxygenator. Finally, it has been recently 
observed that CO2 insufflation is associated with a large number of damaged red blood cells in 
the circuit tubing and its potential clinical effects need to be further investigated [11].  
In conclusion, despite its widespread use, to date there is little evidence on any protective effect 
of CO2 insufflation in open heart surgery. Therefore there is an urgent need for further evidence 
to conclusively justify the routine its use during cardiac surgery.  
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Table 1. Studies overview 
Study CDI 
n 
Control 
n 
Sample size 
calculation 
CDI 
age(SD) 
Control 
age(SD) 
CDI 
M/F 
Control 
M/F 
Type of procedure 
Al-Rashidi 2011 10 10 No 71(13) 70(13) 5/5 5/5 Isolated Valve 85%; CABG+Valve 15% 
Chaudhuri 2012 63 62 No 68(11) 68(12) 31/32 41/21 Isolated Valve 65%, CABG+Valve 35% 
Ganguly  2015 150 150 Yes 43(14) 43(15) 87/63 82/68 Isolated valve: 65%; Isolated CABG 35% 
Kalpokas 2003 10 8 No 62(10) 61(10) 6/4 7/1 Isolated Valve 50%; CABG+Valve 50% 
Martens     2001 31 31 No 62(3) 63(2) 15/16 18/13 Isolated Valve 40%; CABG+Valve 60% 
Martens  2008 39 41 No 66(12) 67(11) 20/19 24/17 Isolated Valve 65%; CABG+Valve35% 
Skidmore 2006 21 22 Yes 61(NR) 60(NR) 13/9 12/10 Isolated Valve 70%; CABG+Valve 30% 
Svenarud 2014 10 10 No 75(13) 75(15) 7/3 6/4 Isolated Valve 60%; CABG+Valve 40% 
 
CO2: Carbon Dioxide; SD: standard deviation; CABG: coronary artery bypass grafting  
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Table 2. Study characteristics 
Study Device Flow Expected Carbon 
dioxide 
concentration 
Primary outcome Method used                    
to quantify cerebral 
microembolization 
Discrimination of 
nature of cerebral 
microemboli 
Outcomes of 
interest reported 
Al-Rashidi 
2011 
Gas diffuser 
(Cardia Innovation AB) 
10L/min 100% air emboli in heart 
chambers using 
TEE 
Microembolic 
signal using TCD 
TCD No death,stroke, heart 
chambers 
microemboli, 
hospital stay 
Chaudhuri 
2012 
Gas diffuser 
(Cardia Innovation AB) 
5L/min 98.5% Neurocognitive 
testing 
air emboli in heart 
chambers using 
TEE 
None - death, stroke, 
NCD, heart 
chambers 
microemboli 
Ganguly 
2015 
vent catheter with 
multiple 
side holes 
5L/min NR Neurocognitive 
testing 
None - death, stroke, NCD 
Kalpokas 
2003 
oxygen cannula 
(Maersk Medical, 
Sydney, Australia) 
6L/min NR air emboli in heart 
chambers using 
TEE 
None - death, stroke, heart 
chambers 
microemboli 
Martens 
2001 
perfusion line 
(2-mm inner diameter) 
3L/min NR Neurocognitive 
testing 
S100B, neuron 
specific enolase 
[NSE] 
None - death, stroke, 
NCD, CK-MB 
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Martens 
2008 
perforated drain 
(Jackson-Pratt) 
2L/min 90% Neurocognitive 
testing 
P300 auditory-
evoked potentials 
None - death, stroke, 
NCD, CK-MB, 
hospital stay 
Skidmore 
2006 
perforated drain 
(Jackson-Pratt) 
6L/min 96% air emboli in heart 
chambers using 
TEE 
Segmenal wall 
motion 
abnormalities 
None - heart chambers 
microemboli, 
hospital stay 
Svenarud 
2014 
Gas diffuser 
(Cardia Innovation AB) 
10L/min 100% air emboli in heart 
chambers using 
TEE 
None - heart chambers 
microemboli, CK-
MB 
 
TCD: transcranial Doppler; TEE: trans-oesophageal echocardiogram; NCD: Neurocognitive deficit    
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Table 3. Neurocognitive tests performed and neurocognitive deficit definition in individual studies.   
 Neurocognitive Tests 
Cognitive domain 
investigated 
Timing of 
neurocognitive tests 
Definition of 
neurocognitive deficit 
Study Finding  
Chaudhuri 
2012 
Six conventional 
neuropsychometric tests 
(Grooved Pegboard, Stroop 
test–Victoria version, Digit Span 
Forward and Digit Span 
Backward, 3 Letter Verbal 
Fluency Test [COWAT-F, A, S 
test], Five Point Design Fluency) 
and 5 tests (International 
Shopping List Delayed Recall, 
Detection Task, 
Identification Task, 1 Back-
Working Memory Task, 1 Card 
Learning Task) on a 
computerized battery (CogState 
Ltd, Melbourne, Australia) were 
used. 
4 domains: psychomotor, 
episodic memory, 
attention and working 
memory, executive 
function. 
Between 1 and 4 weeks 
preoperatively and at 6 
postoperative weeks. 
A change in z score 
between preoperative 
and postoperative test 
performance of 1 SD 
CDI not protective 
Ganguly 
2015 
Mini-Mental State Examination, 
Trail-Making Test B, Digits 
Forward 
and Digits Backward tests, and 
the Wechsler Adult Intelligence 
Scale digit symbol substitution 
test 
8 domains: attention, 
language, verbal 
and visual memory, visual 
construction, executive 
function, psychomotor and 
motor speed 
5 days preoperatively 
and at 1 week and 4 
weeks postoperatively 
when at least 3 tests 
showed a reduction of 
1 SD or when one test 
showed a reduction of 
2 SD and another 
showed a reduction of 
1 SD or more 
CDI protective 
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Martens 
2001 
Block design test (problem 
solving strategies, recognition 
and analysis of forms), Benton 
test (describing constructive 
abilities), Trail making 
(cognitive achievement at 
speed), Digit span (short-term 
memory, memory of figures) and 
d2 test (concentration 
performance) 
Not specified preoperatively 
and 5 days after surgery 
A decline in 
performance from the 
initial test interval that 
exceeded 20% in two 
or more tests was 
considered to 
represent a deficit. 
CDI not protective 
Martens 
2008 
Block design test (problem 
solving strategies, recognition 
and analysis of forms), 
Benton test (describing 
constructive abilities), Trail 
making (cognitive achievement 
at speed), Digit span (short term 
memory, memory of figures) and 
d2 test (concentration 
performance) 
Not specified preoperatively and 5 
days 
after surgery 
A decline in 
performance from the 
initial test interval that 
exceeded 20% in two 
or more tests was 
considered to 
represent a deficit. 
CDI not protective 
CDI: carbon dioxide insufflation   
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Figure legend 
Figure 1. Study flow diagram. 
Figure 2. Risk of bias summary: review authors' judgements about each risk of bias item for 
each included study (top) risk of bias item presented as percentages across all included studies 
(botton) 
Figure 3. Forest plot of comparison: carbon dioxide insufflation (CO2) vs control, outcome: 
in-hospital mortality, stroke, neurocognitive decline.  
Figure 4. Forest plot of comparison: carbon dioxide insufflation (CO2) vs control, outcome: 
quantity of gaseous microemboli in heart chambers; CK-MB and hospital stay length. 
Central Picture. Forest plot for Carbon dioxide insufflation (CO2) vs control on  the 
incidence of postoperative neurocognitive decline 
Video  1. Carbon dioxide insufflation use at Bristol Heart Institute
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